Cargando…
Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiforme
BACKGROUND: As the most aggressive brain tumor, patients with glioblastoma multiforme (GBM) have a poor prognosis. Our purpose was to explore prognostic value of Polo-like kinase 2 (PLK2) in GBM, a member of the PLKs family. METHODS: The expression profile of PLK2 in GBM was obtained from The Cancer...
Autores principales: | Xia, Xiangping, Cao, Fang, Yuan, Xiaolu, Zhang, Qiang, Chen, Wei, Yu, Yunhu, Xiao, Hua, Han, Chong, Yao, Shengtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873877/ https://www.ncbi.nlm.nih.gov/pubmed/31763067 http://dx.doi.org/10.7717/peerj.7974 |
Ejemplares similares
-
Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis
por: Yu, Cheng, et al.
Publicado: (2020) -
Low Expression of APOB mRNA or Its Hypermethylation Predicts Favorable Overall Survival in Patients with Low-Grade Glioma
por: Han, Chong, et al.
Publicado: (2020) -
FOXP4‐AS1 is a favorable prognostic-related enhancer RNA in ovarian cancer
por: Hua, Tian, et al.
Publicado: (2021) -
Exploring the potential biomarkers for prognosis of glioblastoma via weighted gene co-expression network analysis
por: Zhang, Mengyuan, et al.
Publicado: (2022) -
Immune‐relatedlncRNAs can predict the prognosis of acute myeloid leukemia
por: Li, Ran, et al.
Publicado: (2021)